Treatment of borderline personality disorder with olanzapine

Archives of Iranian Medicine

Volumn 9, Issue 4, 2006, Pages 403-405

  Shoja Shafti, Saeed ^a  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Borderline personality disorder; Olanzapine; Pharmacotherapy

Indexed keywords

OLANZAPINE;

ADULT; AGGRESSIVENESS; ARTICLE; BODY WEIGHT DISORDER; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; HUMAN; IMPULSIVENESS; SOMNOLENCE; TREATMENT OUTCOME; TREMOR;

ADULT; ANTIPSYCHOTIC AGENTS; BEHAVIOR; BENZODIAZEPINES; BORDERLINE PERSONALITY DISORDER; FEMALE; HUMANS; TREATMENT OUTCOME;

EID: 33751347885     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000.
2. Hollander E. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder. J Clin Psychiatry. 1999; 60 (suppl 15): 38-44.
3. Soloff PH. Psychopharmacology of borderline personality disorder. Psychiatr Clin North Am. 2000; 23: 169-192, ix.
4. Serban G, Siegel S. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry. 1984; 141: 1455-1458.
5. Rifkin A, Quitkin F, Carrillo C, Blumberg AG, Klein DF. Lithium carbonate in emotionally unstable character disorder. Arch Gen Psychiatry. 1972; 27: 519-523.
6. Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E. An open trial of valproate in borderline personality disorder. J Clin Psychiatry. 1995; 56: 506-510.
7. Chengappa KN, Ebeling T, Kang JS, Levine J, Parepally H. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry. 1999; 60: 477-484.
8. Schulz SC, Camlin KL, Berry SA, Jesberger JA. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry. 1999; 46: 1429-1435.
9. Szigethy EM, Schultz SC. Risperidone in comorbid borderline personality disorder and dysthymia. J Clin Psychopharmacol. 1997; 17: 326-327.
10. Guille C, Sachs GS, Ghaemi SN. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2000; 61: 638-642.